SCHEMBL4420845

SCHEMBL4420845

COc1ccccc1-c1ccc2c(n1)CCC(C)(C)C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.44
PDE4B Q07343 1/20 0.39
GRM2 Q14416 1/20 0.38
HSP90AA1 P07900 2/20 0.37
CRBN Q96SW2 1/20 0.37
ALDH1A1 P00352 2/20 0.37
GSK3A P49840 2/20 0.37
GSK3B P49841 2/20 0.37
PTPN1 P18031 1/20 0.37
METAP2 P50579 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HSP90AB1 P08238 1/20 0.36
ABL1 P00519 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4421902 0.84 ABL1 (0.38) GRM5L3MBTL1PDE4BGRM2HSP90AA1
SCHEMBL13706957 0.80 GRM5 (0.60) GRM5PDE4BALDH1A1MAPTHSD17B10
Hydrochloric Acid SCHEMBL4429413 0.79 GRM5 (0.59) GRM5PDE4BALDH1A1MAPTHSD17B10
SCHEMBL4422696 0.78 GRM5 (0.46) GRM5ALDH1A1GAAMAPTHPGD
SCHEMBL4423540 0.77 GRM5 (0.47) GRM5L3MBTL1PDE4BGRM2HSP90AA1
SCHEMBL4421757 0.77 GRM5 (0.46) GRM5PDE4BALDH1A1MAPTHPGD
SCHEMBL13707023 0.76 GRM5 (0.53) GRM5L3MBTL1HSP90AA1ALDH1A1HPGD
SCHEMBL4433198 0.75 CYP2C19 (0.54) L3MBTL1ALDH1A1GSK3BMAPTHPGD
SCHEMBL13706965 0.73 GRM5 (0.49) GRM5HSP90AA1ALDH1A1HSP90AB1
SCHEMBL27661690 0.72 GSK3A (0.38) L3MBTL1PDE4BGRM2HSP90AA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723116-B1 TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO KGAA (DE) 2008-09-24 EP claimed
US-7598384-B2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors MERZ PHARMA GMBH & CO. KGAA (DE) 2009-10-06 US disclosed
EP-1723116-A2 TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS Merz Pharma GmbH & Co. KGaA (DE) 2006-11-22 EP disclosed
WO-2005082856-A2 TETRAHYDROQUINOLINONES AND THEIR USE AS ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS MERZ PHARMA GMBH & CO. KGAA (DE) 2005-09-09 WO disclosed
US-20050197361-A1 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders MERZ PHARMA GMBH & CO. KGAA (DE) 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197361-A1 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders GRM5, GRIK5, GRIN2C GRM5 1/4885L3MBTL1 944/4885PDE4B 1827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.